B+
Bull case
20%
Probability
Target price
$125.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
BLLN
BillionToOneDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The Q2 print showed strong operating momentum: revenue grew 64%, oncology revenue grew 176%, margins improved, operating income turned positive, and management reiterated substantial 2026 growth guidance. The scheduled Unity and Northstar launches provide additional execution milestones.
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-04 · AMC.
What can break
Analyst estimate revisions, rating changes, and consensus surprise data are unavailable; peer comparisons are informative but not perfectly matched.
Momentum
49
Value
49
Sentiment
36
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $90.00 · Bull $125.00 · Bear $68.00Analysis 2026-08-07; returns require an exact persisted reference.
Earnings
2026-11-04 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-30 • Vendor: Data Vendor v1
Scores
As of 2026-10-30 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-07 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-30
Investment thesis
As of 2026-10-30
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-30. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $129.00
Why
Momentum49 · Δ7d -11.2
Value49 · Δ7d +0.0
Sentiment36 · Δ7d -1.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-04 · AMC.
- • Value remains the lead driver in the composite, 7D delta +0.0.
Contradictions & invalidation
- • Analyst estimate revisions, rating changes, and consensus surprise data are unavailable; peer comparisons are informative but not perfectly matched.
- • CEO open-market sales were reported at prices around $136-$138 before the current $91.65 anchor [#SEC-FORM4-2026-08-05].
- • The deterministic prior remains negative, the post-earnings news flow was adverse, and unchanged guidance provides limited incremental upside after the Q2 print.
Catalyst clock
2026-11-04 · AMC
Q2 growth and profitability confirmation
Lead driver: Value · See fundamentals
Momentum
49
8% active weight
Current posture
7d trendSoftening
Δ7d
-11.2
Δ21d
-30.8
Value
49
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.4
Sentiment
36
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
-16.4
Why this grade
Composite grade D. Momentum 48.9 / Value 48.8 / Sentiment 36.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-07. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$90.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-30
Fundamentals (TTM)
As of 2026-10-30
Market Cap
$5.35B
Beta
-
Shares Out
47.19M
P/E (TTM) · Derived
1779.0
P/S (TTM)
-
P/FCF (TTM) · Derived
168.08
Rev YoY
+64.4%
EPS YoY
-2789.1%
Gross Margin
+71.3%
Op Margin
+10.9%
Net Debt
-$387.08M
Current Ratio
11.69
As of 2026-10-30 • Updated nightlySource: Internal modelMethods & Data